Path ID: DB00277_MESH_D008171_1

db00277-mesh-d008171-1

Concepts

Identifier Name Type
MESH:D013806 theophylline Drug
InterPro:IPR001634 Adenosine receptor GeneFamily
InterPro:IPR023174 3’5’-cyclic nucleotide phosphodiesterase, conserved site GeneFamily
UniProt:Q92769 Histone deacetylase 2 Protein
GO:0016575 histone deacetylation BiologicalProcess
GO:0006198 cAMP catabolic process BiologicalProcess
GO:0019933 cAMP-mediated signaling BiologicalProcess
GO:0006954 inflammatory response BiologicalProcess
GO:0044557 relaxation of smooth muscle BiologicalProcess
HP:4000007 Bronchoconstriction PhenotypicFeature
CHEBI:17489 3’,5’-cyclic AMP ChemicalSubstance
MESH:D008171 Lung Diseases Disease

Relationships

NOTE: predicates are annotated in Biolink Model (v1.3.0)

Subject Predicate Object
Theophylline INCREASES ACTIVITY OF Histone Deacetylase 2
Histone Deacetylase 2 POSITIVELY REGULATES Histone Deacetylation
Histone Deacetylation NEGATIVELY CORRELATED WITH Inflammatory Response
Theophylline DECREASES ACTIVITY OF 3’5’-Cyclic Nucleotide Phosphodiesterase, Conserved Site
Theophylline DECREASES ACTIVITY OF Adenosine Receptor
3’5’-Cyclic Nucleotide Phosphodiesterase, Conserved Site POSITIVELY REGULATES Camp Catabolic Process
3’5’-Cyclic Nucleotide Phosphodiesterase, Conserved Site NEGATIVELY REGULATES Camp-Mediated Signaling
Adenosine Receptor POSITIVELY REGULATES Bronchoconstriction
Bronchoconstriction POSITIVELY CORRELATED WITH Lung Diseases
Adenosine Receptor POSITIVELY REGULATES Inflammatory Response
Camp Catabolic Process DECREASES ABUNDANCE OF 3’,5’-Cyclic Amp
Camp-Mediated Signaling INCREASES ABUNDANCE OF 3’,5’-Cyclic Amp
3’,5’-Cyclic Amp POSITIVELY CORRELATED WITH Relaxation Of Smooth Muscle
3’,5’-Cyclic Amp NEGATIVELY CORRELATED WITH Inflammatory Response
Inflammatory Response POSITIVELY CORRELATED WITH Lung Diseases
Relaxation Of Smooth Muscle NEGATIVELY CORRELATED WITH Lung Diseases

Comment: This disease is also known as Disorder of lung as per DrugCentral. Note this disease name is a very generic term, that could encompass any diseases of the lungs, including neoplasms, infectious diseases (e.g. tuberculosis) and rare diseases (e.g. cystic fibrosis) for which theophylline may not have any therapeutic benefit at all. Therefore, this annotation is done for all lung diseases that could be indications for this drug to encompass diseases that are similar to asthma, bronchitis, COPD and alike.

Reference: